Skip to content

Thursday, April 18, 2024

Latest:

Cancer-predisposition genetic variants associated with adverse outcomes in rhabdomyosarcoma
Collaborating with the community for autism research
Virtual education programs train clinicians around the world
First step to untangle DNA: capture gyrase like a lasso ropes cattle
Protecting your voice at games and concerts

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

CAR T cell therapy

CAR T cell therapy makes strides in tackling Hodgkin lymphoma

August 11, 2020 blood cancer, CAR T cell therapy, fludarabine, Hodgkin lymphoma, Research

CAR-T cell therapy has been used to treat Hodgkin lymphoma with remarkable success for the first time in an early phase clinical trial.

From the Labs Image of the Month:

From the Labs: Human retinal organoid.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951